Type
. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1989;57(3):607-14. Available from: http://ila.ilsl.br/pdfs/v57n3a02.pdf
Type
. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin. Clinical and experimental immunology [Internet]. 1989;77(2):226-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1541994/pdf/clinexpimmunol00083-0072.pdf
Type
. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2. Proceedings of the National Academy of Sciences of the United States of America. 1989;86(16):6269-73.
Type
. Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infection and immunity. 1989;57(8):2475-80.
Type
. [Difficulties in demonstrating Hansen's bacillus in lesions. Analysis of a case]. Medecine tropicale : revue du Corps de sante colonial. 1989;49(3):305-6.
Type
. Dapsone and sulfapyridine. Clinics in dermatology. 1989;7(3):111-20.
Type
. Application of ATP assay for in vitro drug screening testing against human derived M. leprae. Indian journal of leprosy. 1989;61(3):333-44.
Type
. Application of bioluminescent technology to patient care and research in leprosy. Indian journal of leprosy. 1989;61(3):313-22.
Type
. Kellersberger memorial lecture, 1988. Technology for leprosy control--progress and prospects. Ethiopian medical journal. 1989;27(3):161-80.
Type
. Correlation between occurrence of leprosy and fossil fuels: role of fossil fuel bacteria in the origin and global epidemiology of leprosy. Indian journal of experimental biology. 1989;27(6):483-96.